China NMPA Drug Inspection - Changchun Yingping Pharmaceutical Co., Ltd. - Wuling Pain Relief Capsules
China NMPA drug inspection for Changchun Yingping Pharmaceutical Co., Ltd. published March 03, 2020. Drug: Wuling Pain Relief Capsules. On March 3, 2020, the Jilin Provincial Drug Administration published the first issue of its 2020 Drug Quality Bulletin,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Changchun Yingping Pharmaceutical Co., Ltd. published March 03, 2020. Drug: Wuling Pain Relief Capsules. On March 3, 2020, the Jilin Provincial Drug Administration published the first issue of its 2020 Drug Quality Bulletin,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox